Yes. But the other explanation maybe in the health condition of the cohorts used by the doctors in Australia. I don't know how the system works but with a new product I would think the options would be put to the patients. Perhaps the sicker patients took up the offer resulting in the slightly higher adverse events.
Either way I suppose you have to know. But I don't understand why training/documentation would be superior overseas than in Australia. What more does the company need to do better here than overseas?
- Forums
- ASX - By Stock
- No Calcification
Yes. But the other explanation maybe in the health condition of...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.75 |
Change
-0.250(1.67%) |
Mkt cap ! $305.4M |
Open | High | Low | Value | Volume |
$14.50 | $14.94 | $14.25 | $654.2K | 45.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $14.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.83 | 201 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 14.650 |
1 | 1590 | 14.600 |
1 | 300 | 14.560 |
1 | 150 | 14.550 |
1 | 140 | 14.410 |
Price($) | Vol. | No. |
---|---|---|
14.830 | 201 | 2 |
14.840 | 370 | 2 |
14.850 | 150 | 1 |
14.900 | 1000 | 1 |
15.000 | 500 | 1 |
Last trade - 12.48pm 05/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |